Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies

被引:1
|
作者
Wang, Yiting [1 ,2 ]
Shi, Hubing [3 ]
Meng, Huan [4 ]
Xu, Jie [1 ]
机构
[1] Fudan Univ, Inst Biomed Sci, Zhongshan Xuhui Hosp, Key Lab Epigenet & Metab, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Renji Hosp, Shanghai, Peoples R China
[3] Sichuan Univ, State Key Lab Biotherapy, West China Hosp, Chengdu, Peoples R China
[4] Univ Calif Los Angeles, Dept Med, Div Nanomed, Los Angeles, CA 90024 USA
来源
FRONTIERS IN PHARMACOLOGY | 2020年 / 11卷
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
immune checkpoint; cancer therapy; gene regulation; acquired resistance; CAR-T and CAR-NK cell-therapy;
D O I
10.3389/fphar.2020.591188
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页数:3
相关论文
共 50 条
  • [1] Editorial: Targeting the PD-1/PD-L1 cancer immune evasion axis: Challenges and emerging strategies, Volume II
    He, Xiujing
    Xu, Jie
    Meng, Huan
    Shi, Hubing
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] Targeting the PD-1/PD-L1 immune evasion axis with DNA aptamers
    Prodeus, Aaron
    Gariepy, Jean
    [J]. CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
  • [3] Divergent Expression of PD-1 as Challenges and Chances of Immunotherapy Targeting PD-1 or PD-L1 in Cancer
    Huang, Haozhe
    [J]. BIOINFORMATICS AND BIOMEDICAL ENGINEERING, PT II, IWBBIO 2024, 2024, 14849 : 55 - 69
  • [4] Targeting the PD-1/PD-L1 axis for cancer treatment: a review on nanotechnology
    Tran, Tuan Hiep
    Tran, Thi Thu Phuong
    [J]. ROYAL SOCIETY OPEN SCIENCE, 2022, 9 (04):
  • [5] Aptamers Targeting the PD-1/PD-L1 Axis: A Perspective
    Bertrand, Philippe
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2023, 66 (16) : 10878 - 10888
  • [6] Targeting the PD-1/PD-L1 Axis in Human Vitiligo
    Willemsen, Marcella
    Melief, Cornelis J. M.
    Bekkenk, Marcel W.
    Luiten, Rosalie M.
    [J]. FRONTIERS IN IMMUNOLOGY, 2020, 11
  • [7] PD-1/PD-L1 Axis in Lung Cancer
    Santini, Fernando C.
    Hellmann, Matthew D.
    [J]. CANCER JOURNAL, 2018, 24 (01): : 15 - 19
  • [8] PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies
    Lin, Ke Xin
    Istl, Alexandra C.
    Quan, Douglas
    Skaro, Anton
    Tang, Ephraim
    Zheng, Xiufen
    [J]. CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 3875 - 3893
  • [9] PD-1 and PD-L1 inhibitors in cold colorectal cancer: challenges and strategies
    Ke Xin Lin
    Alexandra C. Istl
    Douglas Quan
    Anton Skaro
    Ephraim Tang
    Xiufen Zheng
    [J]. Cancer Immunology, Immunotherapy, 2023, 72 : 3875 - 3893
  • [10] Targeting the PD-1/PD-L1 Immune Evasion Axis With DNA Aptamers as a Novel Therapeutic Strategy for the Treatment of Disseminated Cancers
    Prodeus, Aaron
    Abdul-Wahid, Aws
    Fischer, Nicholas W.
    Huang, Eric H-B
    Cydzik, Marzena
    Gariepy, Jean
    [J]. MOLECULAR THERAPY-NUCLEIC ACIDS, 2015, 4 : e237